LifeStance Health (LFST) Receivables - Net (2020 - 2026)

LifeStance Health (LFST) has 7 years of Receivables - Net data on file, last reported at $122.9 million in Q1 2026.

• Receivables - Net for Q1 2026 came in at $122.9 million, down 12.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $122.9 million (down 12.43% YoY), and the FY2025 annual result was $95.7 million, down 27.38% from the prior year.
• Receivables - Net improved to $122.9 million in Q1 2026 per LFST's latest filing, from $95.7 million in the prior quarter.
• Over five years, Receivables - Net peaked at $175.9 million in Q1 2024 and troughed at $95.0 million in Q1 2022.
• A 5-year average of $127.5 million and a median of $122.9 million in 2026 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2022 and 2025: Receivables - Net surged 66.04% in 2022, then slipped 27.38% in 2025.
• A 5-year view of Receivables - Net shows it stood at $100.9 million in 2022, then gained by 24.33% to $125.4 million in 2023, then increased by 5.1% to $131.8 million in 2024, then fell by 27.38% to $95.7 million in 2025, then rose by 28.43% to $122.9 million in 2026.
• Business Quant data shows LFST's Receivables - Net at $122.9 million in Q1 2026, $95.7 million in Q4 2025, and $121.1 million in Q3 2025.